Teramachi, J
Silbermann, R
Yang, P
Zhao, W
Mohammad, K S
Guo, J
Anderson, J L
Zhou, D
Feng, R
Myint, K-Z
Maertz, N
Beumer, J H
Eiseman, J L
Windle, J J
Xie, X-Q
Roodman, G D
Kurihara, N
Article History
Received: 20 March 2015
Revised: 17 July 2015
Accepted: 27 July 2015
First Online: 19 August 2015
Competing interests
: GDR is a consultant for Amgen. XQX is a consultant for Oxis Biotech. The remaining authors declare no competing financial interests.